Sk Biopharmaceuticals Co Ltd(326030) News

Date	Title
Jan 15	Veeva Systems (VEEV) Offerings Adopted by SK Life Science
Sep 27	SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference